Remcept 8mg. 16mg. 24mg Capsules
PDF Leaflet Revision Date: 29 September 2017
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of mild to moderately severe dementia of the Alzheimer type.
Dosage (summary)
Starting dose: 8 mg/day for 4 weeks; Maintenance: 16 mg/day, may increase to 24 mg/day after assessment.
Onset of Action / Duration
Onset: 1.2 hours, Duration: 7-8 hours
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; potential reproductive toxicity.
Key Drug Interactions
- Other cholinomimetics
- Digoxin
- Beta-blockers
- CYP2D6 inhibitors
- CYP3A4 inhibitors
Contraindications
- Hypersensitivity to galantamine
- Severe hepatic impairment
- Severe renal impairment
- Urinary outflow obstruction
Common side effects
- Nausea
- Vomiting
- Weight loss
- Dizziness
- Bradycardia
Counselling Points
- Take with food
- Monitor for skin reactions
- Avoid driving if dizzy
- Regular follow-up required
Serious warnings
- Serious skin reactions
- Monitor weight
- Caution in cardiac disorders
- Seizures reported
Important Disclaimer
The Remcept 8mg. 16mg. 24mg Capsules professional information leaflet below is the property of Actavis Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
